The parallel distributor informed its supplied customers on 03.06.2014 and asked for a stock check of the affected batches.

The parallel distributor informed its supplied customers on 04.06.2014 and asked for a stock check of the affected batches.

The parallel distributor informed its supplied customers on June 4, 2014 and asked for a stock check of the affected batches.

Update on stolen vials of Herceptin and other products, newly affected: Avastin and MabThera

The BASG dissociates itself from statements on the homepage of the manufacturer of the unapproved drug "Reniale

In a letter dated May 26, 2014, the marketing authorization holder informed its customers that the degree of discoloration of batch 2G605A is just outside the permitted limit and the impurities are elevated. For batch 2M631A, although the degree of discoloration is within the allowed limit, the measured value for impurity B is 0.7%, which is above…

The marketing authorization holder has informed its supplied customers by letter dated 21.05.2014 that the above batch is being recalled as a precautionary measure due to possible particles.

European Commission orders withdrawal of approval for metoclopramide-containing medicines in drop form with a concentration higher than 1 mg/ml.

The epidemic of Ebola virus disease (EVD) in West Africa in 2014 has increased the risk of Ebola virus transmissionvia donated blood and blood components, cells, tissues and organs(substances of human origin -SoHO).

The marketing authorization holder informed its supplied customers by letter dated April 24, 2014, that due to the implementing decision C(2013)9846 in the context of the European risk assessment procedure according to Article 31 of Directive 2011/83/EC, the marketing authorization for "Metogastron 4 mg/ml Drops" will be withdrawn as of April 30,…